TGFB1 and pancreatic neoplasm: As expected, Greco et al. [263] verified that TGF-β blockade using a neutralizing antibody significantly improves overall mortality, weight loss, fat mass, lean body mass, bone mineral density, and skeletal muscle proteolysis in mice with advanced pancreatic cancer.